List view / Grid view

Boehringer Ingelheim

news

Sandoz to give insight on European biosimilar trends at 7th Annual Congress

21 July 2016 | By SMi Group

Sandoz added onto Biosimilars Europe speaker line-up alongside ABPI, IMS Health and Boehringer Ingelheim...

news

A new, highly accurate way of proving how new drugs work

6 July 2016 | By Cold Spring Harbor Laboratory (CSHL)

Researchers have identified a new drug target in AML, created a candidate drug that hits the target and developed a new way of proving how the drug works...

news

Boehringer Ingelheim and Inventiva enter IPF collaboration

31 May 2016 | By Victoria White, Digital Content Producer

Boehringer Ingelheim and Inventiva have entered a research and drug discovery collaboration with the aim of discovering new IPF treatments...

news

Project to apply crowdsourcing for new treatment approaches for psychiatric diseases

23 May 2016 | By Victoria White, Digital Content Producer

Boehringer Ingelheim and BioMed X have established a research team that will conduct research to identify new treatment approaches for psychiatric diseases...

news

LDC and Boehringer Ingelheim join forces to discover schizophrenia treatment

11 May 2016 | By Victoria White, Digital Content Producer

Boehringer Ingelheim will have the option of exclusive rights to a new compound for the treatment of schizophrenia to be discovered and developed at the LDC...

news

VTU Technology and Boehringer Ingelheim extend collaboration

27 April 2016 | By Victoria White, Digital Content Producer

After successful completion of a first development programme, Boehringer Ingelheim is now widening the scope of its collaboration with VTU Technology...

news

Amal Therapeutics completes EUR 2.75 million Series A financing round

30 March 2016 | By Victoria White

Amal Therapeutics will use the funds to progress the preclinical development of ATP124 and to further develop its KISIMA technology platform...

Pushing the limits of protein expression with miRNAs

article

Pushing the limits of protein expression with miRNAs

17 March 2016 | By Kerstin Otte Biberach (University of Applied Sciences), René Handrick (University of Applied Sciences), Simon Fischer (Boehringer Ingelheim)

Biopharmaceuticals are highly complex protein drugs such as antibodies, cytokines and peptide hormones, which are used for a variety of indication areas, including immunology, neurology, metabolic diseases and cancer. These modern protein drugs may hinder progression of a disease, ease symptoms or assure – in the case of chronic diseases…

news

Winners of innovative cardiovascular research grant programme announced

11 February 2016 | By Victoria White

The European Society of Cardiology awarded the grants to research projects that will address areas of unmet medical need in thromboembolic disease...

news

Boehringer and Arena to advance research in psychiatric diseases

13 January 2016 | By Victoria White

Boehringer Ingelheim and Arena Pharmaceuticals have signed an exclusive agreement to conduct joint research to identify drug candidates for psychiatric diseases...

news

Boehringer Ingelheim and MD Anderson in pancreatic cancer collaboration

2 December 2015 | By Victoria White

Boehringer Ingelheim and The University of Texas MD Anderson Cancer Centre are to focus on developing new medicines for pancreatic ductal adenocarcinoma...

news

Boehringer Ingelheim pledges EUR 11 billion to R&D

11 November 2015 | By Victoria White

Of the total investment, EUR 5 billion will go to preclinical R&D with EUR 1.5 billion thereof planned for collaborations with external partners...

news

Boehringer Ingelheim announces IBD research collaborations

10 November 2015 | By Victoria White

The collaborations aim to identify and validate potential new therapeutic targets as well as identify biomarkers...

news

Collaboration to investigate acute myeloid leukaemia therapeutic approaches

12 October 2015 | By Victoria White

Boehringer Ingelheim and Philogen have agreed on an exploratory trial investigating novel immunotherapy concepts for relapsed acute myeloid leukaemia patients...

news

Global and USA Biosimilar Market: Latest updates from Hospira, Sandoz, Merck, Teva, Boehringer Ingelheim

7 October 2015 | By SMi Group

Leading organizations in the Biosimilars Development sector will meet at Biosimilars and Biobetters USA 2015 – the must-attend premier industry event which will take place in Iselin this November...

Cookie	Type	Duration	Description
cookielawinfo-checkbox-advertising-targeting	persistent	1 year	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics	persistent	1 year	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary	persistent	1 year	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	persistent	1 year	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID	session	1 year	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy	persistent	1 year	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged	session	1 year	This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.

Cookie	Type	Duration	Description
advanced_ads_browser_width	persistent	1 month	This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions	persistent	2 years	This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info	persistent	1 month	This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer	persistent	1 year	This cookie is set by Advanced Ads and sets the referrer URL.
bscookie	persistent	2 years	This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE	persistent	2 years	This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr	persistent	3 months	This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory	persistent	1 month	This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE	persistent	5 months	This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.

Cookie	Type	Duration	Description
bcookie	persistent	2 years	This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS	persistent	30 minutes	This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang	session	1 year	This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc	persistent	1 day	This cookie is set by LinkedIn and used for routing.
lissc	persistent	11 months	This cookie is set by LinkedIn share Buttons and ad tags.
vuid	persistent	2 years	We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId	persistent	2 years	This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule	persistent	20 minutes	This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session	persistent	20 minutes	This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues	persistent	20 minutes	This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga	persistent	2 years	This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat	persistent	1 minute	This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid	persistent	1 day	This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.

Cookie	Type	Duration	Description
cf_ob_info	persistent	1 minute	This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob	persistent	1 minute	This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only	session	1 year	This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush	persistent	1 month	This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db	persistent	Until cleared	This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC	session	1 year	This cookie is set by Youtube and is used to track the views of embedded videos.

Recommended

Boehringer Ingelheim